Watson syndrome

Watson syndrome is a rare genetic disorder caused by mutations in the NF1 gene located on chromosome 17q11.2, the same gene responsible for neurofibromatosis type 1 (NF1). It is considered an allelic variant of NF1 and shares some overlapping features. Watson syndrome is characterized by the combination of café-au-lait spots (flat, pigmented skin patches), pulmonary valve stenosis (narrowing of the pulmonary valve of the heart), intellectual disability of variable degree, and short stature. Some patients may also exhibit features seen in NF1 such as Lisch nodules (pigmented hamartomas of the iris) and axillary or inguinal freckling, though the full spectrum of NF1 manifestations (such as neurofibromas) may be less prominent. The condition affects multiple body systems including the skin, cardiovascular system, and central nervous system. Pulmonary valve stenosis is a distinguishing cardiac feature that differentiates Watson syndrome from classic NF1 and requires cardiac evaluation and monitoring. Intellectual disability ranges from mild to moderate in most reported cases. Growth may be affected, with short stature being a common finding. There is no cure for Watson syndrome, and management is symptomatic and supportive. Cardiac involvement, particularly pulmonary stenosis, may require intervention ranging from monitoring to balloon valvuloplasty or surgical correction depending on severity. Developmental support, educational interventions, and regular monitoring for complications associated with NF1-spectrum disorders (including screening for tumors and ophthalmologic evaluations) are recommended. Genetic counseling is important for affected families given the autosomal dominant inheritance pattern.

Common questions about Watson syndrome